Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|3|373-378

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.3, 2015-03, pp. : 373-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non‐motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non‐motor subtypes

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 1145-1150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased bilirubin levels in de novo Parkinson's disease

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 954-959

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 12, 2015-12 ,pp. : 1564-1572

John Wiley & Sons Inc

Access to resources Recommend Favorite

Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 540-546

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular Effects of Levodopa in Aged versus Younger Patients with Parkinson's Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 24, Iss. 4, 1976-04 ,pp. : 185-188

John Wiley & Sons Inc

Access to resources Recommend Favorite